New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells from patients with X-linked chronic ...
Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction. If you don't have a login or your access has expired, you will need to ...